News
14 July 2026
Universal Brain has received US Food and Drug Administration (FDA) 510(k) clearance for its UB ERP System, a brain function assessment platform designed for use in psychiatry. The system uses electroencephalography (EEG) and event-related potentials (ERPs) to provide objective measurements of brain function.
Read more...10 July 2026
Amprion and Modality.AI have announced a collaboration to explore how molecular biomarkers and AI-based digital assessments can be combined to improve the understanding and evaluation of neurodegenerative diseases.
Read more...Abbisko Therapeutics has entered into a strategic collaboration with AstraZeneca to jointly advance the clinical development of a combination therapy for non-small cell lung cancer (NSCLC).
Read more...OrthAlign, Inc. has announced the successful completion of the first clinical cases using its Lantern ASC system, a handheld surgical technology developed for the ambulatory surgery centre (ASC) environment.
Read more...Moon Surgical and Uncovr have completed the first 20 clinical cases using automated operative reporting on the Maestro Platform, powered by Moon Surgical's Software Version 2.7.
Read more...SetPoint Medical has announced the first use of its SetPoint System® in North Carolina in collaboration with Arthritis & Osteoporosis Consultants of the Carolinas (AOCC), the largest independent rheumatology practice in the southeastern United States.
Read more...26 June 2026
Intelivation Technologies today announced the successful first clinical use of its Advantage-C™ Ti3D Cervical Interbody Device.
Read more...Valgen Medtech recently announced that its proprietary DragonFly™ Transcatheter Mitral Valve Repair System has received CE mark approval in the European Union for the treatment of Functional Mitral Regurgitation (FMR).
Read more...Dexcom has announced several developments aimed at expanding access to glucose biosensing technology, including FDA clearance for paediatric use of its Stelo Glucose Biosensor and the launch of a redesigned Stelo mobile application in the United States.
Read more...HistoSonics, developer of the Edison® Histotripsy System and histotripsy therapy platforms, has completed a new financing round with participation from Yosemite, led by Reed Jobs, along with several new strategic investors. Financial details of the investment were not disclosed.
Read more...